U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
101851101851Donor Human Milk and Neurodevelopmental Outcomes in Very Low Birthweight (VLBW) InfantsActive, not recruitingNo Results AvailableNeurodevelopmental Outcomes of VLBW InfantsDietary Supplement: Donor Human Milkhttps://ClinicalTrials.gov/show/NCT01232725
101852101852A Study to Assess the Safety and Efficacy of MUC1 Peptide Vaccine and hGM-CSF in Patients With MUC1-positive Tumor MalignanciesCompletedNo Results AvailableMultiple MyelomaBiological: ImMucin, hGM-CSFhttps://ClinicalTrials.gov/show/NCT01232712
101853101853Internet Obesity Treatment Enhanced With Motivational InterviewingCompletedNo Results AvailableObesityBehavioral: Internet Obesity Treatment|Behavioral: Internet Obesity Treatment with MI|Behavioral: Contingent MIhttps://ClinicalTrials.gov/show/NCT01232699
101854101854Snow Disease Surveillance System StudyEnrolling by invitationNo Results AvailableCommunicable DiseasesOther: Online disease surveillance data accesshttps://ClinicalTrials.gov/show/NCT01232686
101855101855Autologous Bone Marrow Stem Cell Transfer in Patients With Chronical Critical Limb Ischemia and Diabetic FootCompletedNo Results AvailableCritical Limb IschemiaProcedure: BMAC application in Critical Limb Ischemiahttps://ClinicalTrials.gov/show/NCT01232673
101856101856Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART)RecruitingNo Results AvailableHIV InfectionDrug: Hydroxychloroquinehttps://ClinicalTrials.gov/show/NCT01232660
101857101857Vitamin K as Additive Treatment in OsteoporosisNot yet recruitingNo Results AvailablePost-Menopausal OsteoporosisDrug: Phylloquinone|Drug: Menaquinone (MK4)|Drug: placebohttps://ClinicalTrials.gov/show/NCT01232647
101858101858Validation of Ultrasound as a Diagnostic Tool for Assessment of Hemophilic Arthropathy of Knees and AnklesRecruitingNo Results AvailableHemophilia|Hemophilic Arthropathyhttps://ClinicalTrials.gov/show/NCT01232634
101859101859The Approach StudyCompletedNo Results AvailableCritical Care Trial Participation Consent by SDMOther: Physician Introduction of research personnelhttps://ClinicalTrials.gov/show/NCT01232621
101860101860Exercise Training in Patients With Coronary Heart Disease and Type 2 DiabetesCompletedNo Results AvailableCoronary Artery Disease|Diabetes Mellitus, Type 2|AtherosclerosisBehavioral: Exercisehttps://ClinicalTrials.gov/show/NCT01232608
101861101861Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile InfectionsCompletedNo Results AvailableModerate Clostridium Difficile InfectionDrug: LFF571|Drug: Vancomycin (POC)https://ClinicalTrials.gov/show/NCT01232595
101862101862Safety and Efficacy of MRgFUS for the Treatment of Low Back PainCompletedNo Results AvailableLower Back Pain, Facets Joints OsteoarthritisDevice: Exablate treatmenthttps://ClinicalTrials.gov/show/NCT01232582
101863101863A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedHas ResultsRheumatoid ArthritisDrug: Tocilizumab 162 mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01232569
101864101864A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose ChemotherapyTerminatedNo Results AvailableLymphoma, Non-HodgkinDrug: Inotuzumab ozogamicin|Drug: Rituximab|Drug: rituximab + gemcitabine|Drug: rituximab +bendamustinehttps://ClinicalTrials.gov/show/NCT01232556
101865101865Safety Study Evaluating the Adrenal Suppression Potential of Product 0405 in Pediatric Subjects With Atopic DermatitisCompletedNo Results AvailableAtopic DermatitisDrug: Product 0405https://ClinicalTrials.gov/show/NCT01232543
101866101866Pharmacovigilance for ACTs in AfricaCompletedNo Results AvailableMalariahttps://ClinicalTrials.gov/show/NCT01232530
101867101867NeuroVision® Dynamic Screw Test StudyCompletedNo Results AvailableDegenerative Spinal Conditionshttps://ClinicalTrials.gov/show/NCT01232517
101868101868Antifugal Effect of Recombinant Human Granulocyte-macrophage Stimulating Factor (rhGM-CSF) in Patients Post Allo-HSCTCompletedHas ResultsMycosesDrug: rhGM-CSF group|Drug: rhG-CSF+rhGM-CSF group|Drug: rhG-CSF grouphttps://ClinicalTrials.gov/show/NCT01232504
101869101869Impact of Dietary Intervention on Weight Change in Subjects With Type 2 DiabetesCompletedHas ResultsDiabetes|Diabetes Mellitus, Type 2Drug: insulin detemir|Dietary Supplement: dietary regimenhttps://ClinicalTrials.gov/show/NCT01232491
101870101870I Change Adherence & Raise ExpectationsCompletedNo Results AvailableCystic FibrosisBehavioral: Comprehensive Adherence Program (CAP)https://ClinicalTrials.gov/show/NCT01232478
101871101871Impact of Sperm DNA Integrity on In Vitro CyclesCompletedHas ResultsMale Infertility|Unexplained Infertility|Abortion, Habitualhttps://ClinicalTrials.gov/show/NCT01232465
101872101872A Study in Non-Small Cell Lung CancerActive, not recruitingNo Results AvailableNon-Small-Cell Lung CarcinomaDrug: Pemetrexed|Drug: Cisplatin|Drug: Cixutumumabhttps://ClinicalTrials.gov/show/NCT01232452
101873101873A Study of Brain Receptor Occupancy in Healthy SubjectsCompletedNo Results AvailableAlcohol DependenceDrug: opioid receptor kappa antagonisthttps://ClinicalTrials.gov/show/NCT01232439
101874101874A Randomized Controlled Trial of the Treatment of Mallet FracturesRecruitingNo Results AvailableMallet FractureProcedure: Biodegradable Meniscus Arrow®|Device: Mallet splinthttps://ClinicalTrials.gov/show/NCT01232426
101875101875A Study of the Effect of ASP1941 on Cardiac Repolarization in Healthy SubjectsCompletedNo Results AvailableHealthy Subjects|Cardiac RepolarizationDrug: Placebo|Drug: ASP1941|Drug: Moxifloxacinhttps://ClinicalTrials.gov/show/NCT01232413
101876101876Study to Evaluate Esmolol (Brevibloc) to Manage Cardiac Function in Patients With Subarachnoid HemorrhageWithdrawnNo Results AvailableSubarachnoid HemorrhageDrug: Esmololhttps://ClinicalTrials.gov/show/NCT01232400
101877101877Identification of Early Predictors of Fetomaternal HemorrhageCompletedNo Results AvailableFetomaternal Hemorrhage|Neonatal Anemiahttps://ClinicalTrials.gov/show/NCT01232387
101878101878Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell CarcinomaActive, not recruitingNo Results AvailableSquamous Cell CarcinomaDrug: Nimotuzumab|Drug: Placebo|Drug: cisplatin|Radiation: Radiotherapyhttps://ClinicalTrials.gov/show/NCT01232374
101879101879IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and AdolescentsEnrolling by invitationNo Results AvailableADHD|HIVhttps://ClinicalTrials.gov/show/NCT01232361
101880101880Symbicort Turbuhaler 30/60 Clinical Experience InvestigationCompletedNo Results AvailableBronchial Asthmahttps://ClinicalTrials.gov/show/NCT01232348

* Görseller ve İçerik tekif hakkına sahip olabilir